Inhibition of IGF1R affects Ewing's sarcoma cell growth in vivo [27,28] and seems to sensitize sarcoma cells to conventional agents by a synergistic interaction, suggesting a therapeutic combination approach [29,30]. The gene discussed is IGF1R; the disease is sarcoma.